Skip to content
type1.science
Phase 1/2RecruitingNCT03746769

Gastrin to improve islet transplantation outcomes

Phase 1/2 trial testing whether gastrin can improve donor-islet transplant outcomes in type 1 diabetes.

Primary endpoints

  • Proportion of subjects who are insulin independent, free from severe hypoglycemia and have HbA1c less than or equal to 6.5% ("complete response")

Results so far

No results posted yet.